ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Tocilizumab for severe and refractory mucous membrane pemphigoid.
Billal Tedbirt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it